Delivery Order SPE2DB22D2206-SPE2DB24FKF01

Award Date 9/9/24
Potential Completion Date 9/30/24
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of RYANODEX 250 MG VIALS. The contract has a ceiling value of $4,468.92 and a completion date of August 19, 2024. AmerisourceBergen, a for-profit organization, is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of essential medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The order is for 4,565,338,781 units of the pharmaceutical product RYANODEX 250 MG VIALS, with a ceiling value of $2,979.28. The contract is a firm fixed-price delivery order with an ultimate completion date of August 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RYANODEX 250 MG VIALS. The contract has a ceiling value of $1,489.63 and an ultimate completion date of September 4, 2024. It is a firm fixed-price contract, without any set-aside designation. Amerisourcebergen's Corporate Office Division, which is a for-profit organization, will be performing the contract at a location in...
This is a contract award to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distribution company, to provide RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,448.20 and is a Firm Fixed Price Delivery Order, with a completion date of July 9, 2024. The contract is not set aside and was awarded on June 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract, awarded to AmerisourceBergen Drug Corp's Corporate Office Division, has a ceiling value of $5,958.56 and a completion date of July 23, 2024. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,632.64 and is a Firm Fixed Price Delivery Order for the supply of RYANODEX 250 MG VIALS. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of RYANODEX 250 MG VIALS (4564821330) to the Defense Logistics Agency (DLA), a defense agency. The firm-fixed-price delivery order, valued at $2,979.28, has an ultimate completion date of June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This is a $4,468.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 250mg vials of the pharmaceutical product Ryanodex, with a period of performance through October 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply medical commodities and prescription drugs to various military treatment facilities,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials. The contract has a ceiling value of $4,468.92 and a period of performance through September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by defense and civilian agencies to provide a wide range of essential...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RYANODEX 250 MG VIALS. The contract has a completion date of February 14, 2024 and a potential value of $2,979.28. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards to supply pharmaceuticals, medical supplies, and related distribution services in...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKF01
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RYANODEX 250 MG VIALS. The contract has a ceiling value of $5,958.56 and a period of performance through September 30, 2024. It is a firm-fixed-price contract, with no set-aside designation.

AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, for delivering a wide range of pharmaceutical and medical supplies to support federal healthcare programs and military treatment facilities. This delivery order is likely part of the company's broader contractual relationships with these government agencies to provide critical care medications and medical commodities to military personnel, veterans, and other federal beneficiaries.

Generated 12/9/24, 2:08 PM